Advertisement

Topics

ASIT Biotech's Novel Grass Allergy Product Needs Second Phase III Study

07:43 EDT 22 Jun 2017 | SCRIP

Belgium’s ASIT biotech hopes to succeed in the difficult allergy market with a more focused Phase III study of its...

      

Related Stories

 

Original Article: ASIT Biotech's Novel Grass Allergy Product Needs Second Phase III Study

NEXT ARTICLE

More From BioPortfolio on "ASIT Biotech's Novel Grass Allergy Product Needs Second Phase III Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...